ArticleThe journal of liquid biopsy2026
Storage-dependent changes in the soluble urinary proteome: a pre-analytical stability study in inflammatory clinical urine samples.
Article in The journal of liquid biopsy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urine is a highly accessible biofluid for clinical proteomics, but pre-analytical variability during collection, storage, and processing can compromise reproducibility. Mass spectrometry-based proteomics enables broad measurement of urinary proteins, making it suitable for evaluating how storage conditions affect proteome composition. However, clinical translation of urinary proteomics is limited by insufficient standardization of pre-analytical workflows and limited knowledge of proteome stability during storage, compromising reproducibility. This limitation is particularly relevant for inflammatory urine samples, where immune-cell-derived and complement-associated proteins may continue to change ex vivo during delayed processing. Here, we systematically evaluated the stability of the soluble urinary proteome under clinically relevant storage conditions. Urine samples from patients with pyelonephritis were used as a clinically relevant inflammatory urine model and processed under six pre-analytical storage conditions, including immediate freezing at -80 °C, repeated freeze-thaw cycles, and incubation for 30 min or 3 h at either 4 °C or room temperature prior to freezing. High-resolution proteomics using data-independent acquisition coupled with parallel accumulation-serial fragmentation (DIA-PASEF) identified more than 4,300 protein groups across four pyelonephritis patients. Global proteome profiles were highly reproducible across all conditions (Pearson r > 0.9). In contrast, specific immune and metabolic proteins exhibited storage-dependent abundance changes, particularly after prolonged room temperature exposure, consistent with ex vivo immune activation. These results support standardized urine handling, particularly avoidance of prolonged room-temperature storage, to reduce storage-induced changes in immune-associated urinary proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.